Next Financial Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $657K | Buy |
5,067
+3,130
| +162% | +$406K | 0.04% | 438 |
|
|
2021
Q3 | $219K | Buy |
1,937
+237
| +14% | +$26.8K | 0.02% | 795 |
|
|
2021
Q2 | $176K | Buy |
1,700
+54
| +3% | +$5.59K | 0.01% | 878 |
|
|
2021
Q1 | $137K | Sell |
1,646
-48
| -3% | -$4K | 0.01% | 900 |
|
|
2020
Q4 | $154K | Sell |
1,694
-330
| -16% | -$30K | 0.01% | 810 |
|
|
2020
Q3 | $162K | Sell |
2,024
-1,114
| -36% | -$89.2K | 0.02% | 696 |
|
|
2020
Q2 | $217K | Sell |
3,138
-666
| -18% | -$46.1K | 0.03% | 513 |
|
|
2020
Q1 | $239K | Buy |
3,804
+456
| +14% | +$28.7K | 0.03% | 483 |
|
|
2019
Q4 | $260K | Buy |
3,348
+1,362
| +69% | +$106K | 0.03% | 599 |
|
|
2019
Q3 | $146K | Sell |
1,986
-90
| -4% | -$6.62K | 0.02% | 784 |
|
|
2019
Q2 | $128K | Buy |
2,076
+1,026
| +98% | +$63.3K | 0.01% | 826 |
|
|
2019
Q1 | $67K | Buy |
+1,050
| New | +$67K | 0.02% | 649 |
|
|
2017
Q4 | – | Sell |
-5,091
| Closed | -$184K | – | 591 |
|
|
2017
Q3 | $184K | Hold |
5,091
| – | – | 0.05% | 340 |
|
|
2017
Q2 | $201K | Buy |
5,091
+1,956
| +62% | +$77.2K | 0.05% | 349 |
|
|
2017
Q1 | $115K | Buy |
3,135
+1,500
| +92% | +$55K | 0.03% | 449 |
|
|
2016
Q4 | $51K | Hold |
1,635
| – | – | 0.01% | 953 |
|
|
2016
Q3 | $66K | Buy |
+1,635
| New | +$66K | 0.01% | 821 |
|
|
2014
Q4 | – | Sell |
-1,686
| Closed | -$29K | – | 2014 |
|
|
2014
Q3 | $29K | Sell |
1,686
-1,200
| -42% | -$20.6K | 0.01% | 1219 |
|
|
2014
Q2 | $46K | Buy |
+2,886
| New | +$46K | 0.02% | 364 |
|